Arabic Arabic English English French French German German

Advancing Generic Drug Development: Translating Science to Approval, Day One Closing Remarks

Lei Zhang, PhD, Deputy Director for the Office of Regulatory Science, delivers closing remarks to conclude day one of the Advancing Generic Drug Development conference.
For slides and additional information:
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Upcoming Training –
SBIA Listserv –
SBIA 2021 Playlist –
SBIA LinkedIn –
SBIA Training Resources –
Twitter –
Email –
Phone – (301) 796-6707 I (866) 405-5367

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Complex Generics: Complex Injectables, Ophthalmic, and Otic Products, Part 2

Next Post

The potential of natural extracts to reduce the reproductive capacity of the SARS-CoV-2 virus

Related Posts